Navi Medical Technologies awarded NHMRC grant
Congratulations to MedTech Actuator alumnus Navi Medical Technologies, awarded an NHMRC Development Grant worth almost $900,000.
The NHMRC’s Development Grant scheme helps take research to the proof-of-concept stage, a critical step on the pathway to successful commercialisation. Each Development Grant application was assessed by up to 10 peer reviewers: five scientific reviewers and five commercial reviewers. This speaks volumes for the quality of Navi’s application and the value of the work they are doing to improve the care of vulnerable neonates.
In partnership with the University of Melbourne, The Royal Women’s Hospital and The Royal Children’s Hospital the funds will be used to expand Navi’s research into central line management in older children.
The NHMRC is one of the ten largest funders of health research in the world. It only invests in the highest quality health and medical research and the best researchers and supports the translation of scientific discoveries to benefit communities in Australia and around the world.
Congratulations to (L-R) Christiane Theda, Brad Bergmann, Shing Yue Sheung, Mubin Yousuf, Wei Sue and Alexander Newton.
In the last three months Navi have also commenced their first-in-human research at the Royal Women’s Hospital neonatal intensive care unit, using their prototype on newborns for the first time. They have received a Victorian Medical Research Acceleration Fund grant to expand research in the Royal Women’s Hospital to adjacent newborn procedures, and won funding from the US FDA-funded National Capital Consortium for Pediatric Device Innovation.
Story adapted from content courtesy of Lance Chia GAICD, Liverpool Innovation Precinct.